(RTTNews) -  CardioGenics Holdings Inc. (CGNH.OB: News ) reported that Merck Chimie S.A.S. is progressing to the next phase of the commercialization of CardioGenics' proprietary silver coated paramagnetic Beads.

As per the agreement with Merck Chimie that was executed earlier this year, CardioGenics supplied Merck Chimie with its proprietary silver coated paramagnetic beads for polymer encapsulation by Merck Chimie using their proprietary polymer process.

CardioGenics said that Merck Chimie has informed it that its proprietary encapsulation of the Beads was successful and that they will start shipping the encapsulated Beads to CardioGenics for testing in December.
CardioGenics intends to meet with Merck Chimie in early 2010 to examine the test results against Merck Chimie's predetermined quality specifications for the encapsulated Beads.

Click here to receive FREE breaking news email alerts for CardioGenics Holdings Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com